Oct 31, 2016 - Mike Sathekge, Department of Nuclear Medicine, Steve Biko Academic Hospital, ...... The first case was reported in 1829 by Sir Ashley. 565.
Accepted Manuscript Title: Imaging in Extrapulmonary Tuberculosis Author: Sanjay Gambhir Mudalsha Ravina Kasturi Rangan Manish Dixit Sukanta Barai Jamshed Bomanji PII: DOI: Reference:
S1201-9712(16)31220-6 http://dx.doi.org/doi:10.1016/j.ijid.2016.11.003 IJID 2766
To appear in:
International Journal of Infectious Diseases
Received date: Revised date: Accepted date:
12-10-2016 31-10-2016 1-11-2016
Please cite this article as: Gambhir S, Ravina M, Rangan K, Dixit M, Barai S, Bomanji J, the International Atomic Energy Agency extra-pulmonary TB Consortium,1 Imaging in Extrapulmonary Tuberculosis, International Journal of Infectious Diseases (2016), http://dx.doi.org/10.1016/j.ijid.2016.11.003 This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
1 2 3
HIGHLIGHTS Diagnosis of Extra-pulmonary tuberculosis (EPTB) remains challenging due to
5
protean clinical manifestations and difficulties in making accurate diagnosis.
6
Advances in imaging technologies now allow for accurate localization of diseased
ip t
4
sites and access to obtaining biological samples for microbiological, histo-
8
pathological and molecular testing.
10
Evidence is building towards use of newer imaging modalities for monitoring response to treatment and for relapse.
us
9
cr
7
11
an
12 13 14
Ac ce
pt
ed
M
15
1 Page 1 of 33
Review for IJID series for World TB Day 2017
15 16
Title:
17
Imaging in Extrapulmonary Tuberculosis
18
Authors:
20
Sanjay Gambhir^, Mudalsha Ravina^, Kasturi Rangan^, Manish Dixit^, Sukanta Barai^,
21
Jamshed Bomanji#, and *the International Atomic Energy Agency extra-pulmonary TB
22
Consortium*
cr
us
Institutional affiliations: # Department of Nuclear Medicine, of Nuclear Medicine, UCLH NHS Foundation Trust London, UK
an
23 24 25 26 27 28
ip t
19
^Sanjay Gandhi Post Graduate Institute of Nuclear Medicine, Lucknow India and Institute
29
*the International Atomic Energy Agency extra-pulmonary TB Consortium: Rajnish Sharma,
31
Bhagwant Rai Mittal, Sanjay Gambhir, Ahmad Qureshy, Shamim Momtaz Ferdousi Begum,
32
Mike Sathekge, Mariza Vorster, Dragana, Sobic Saranovic, Pawana Pusuwan, Vera Mann,
33
Shobhan Vinjamuri, Allimudin Zumla, Thomas Pascual, Jamshed Bomanji -author affiliations
34
below-next page) .
ed
pt
36 37 38 39 40 41 42 43 44 45 46 47
Keywords: Tuberculosis, Imaging, CT, PET-CT, MRI, extrapulmonary tuberculosis, diagnosis, biomarker, , 18F-fluorodeoxyglucose (FDG) PET-CT
Ac ce
35
M
30
Corresponding Authors: Dr Jamshed Bomanji MBBS, PhD, FRCR, FRCP Institute of Nuclear Medicine, 5th Floor, UCLH NHS Foundation Trust, 235 Euston Road,London NW1 2BU Email:jamshed.bomanji@nhs.net Prof. Sanjay Gambhir, MBBS, DNB Nuclear Medicine, SGPGIMS, Lucknow, India, Head, Nuclear Medicine Sanjay Gandhi Post Graduate Institute of Medical Science, Rae Bareli Road, Lucknow, India Tel:+91 522 2494623 Fax: +91 522 2668017 Email:gaambhir@yahoo.com
48
2 Page 2 of 33
48
AUTHOR AFFILIATIONS: for the International Atomic Energy Agency extra-pulmonary TB
49
Consortium*
50 51 52
Rajnish Sharma, Director & Head , Division of Nuclear Medicine & PET Imaging, Specialist in Nuclear Medicine &Thyroid diseases, Molecular Imaging & Research Center ( MIRC), INMAS, Delhi. Email: drrsms@rediffmail.com
53
cr
ip t
Bhagwant Rai Mittal, Director & Head, Dept. of Nuclear Medicine & PET, Post Graduate Institute of Medical Education and Research, Sector 12, Chandigarh – 160012, India. Email: brmittal@yahoo.com
Sanjay Gambhir, Director and Head, Dept. of Nuclear Medicine, SGPGIMS, Rae Bareli Road, Lucknow-226014 Email: gaambhir@yahoo.com
us
54 55 56 57 58 59 60
Ahmad Qureshy, INMOL Hospital, New Campus Road, Lahore 54600, Pakistan,
62
Email: aqureshy@yahoo.com
an
61
M
63
Shamim Momtaz Ferdousi Begum, National Institute of Nuclear Medicine & Allied Sciences (NINMAS) 7th–10th Floor, Block-D, BSM Medical University Campus, Shahbag, Dhaka-1000. Email: pragyna06@yahoo.com
68 69
Mike Sathekge, Department of Nuclear Medicine, Steve Biko Academic Hospital, University of Pretoria, Pretoria, South Africa. Email: mike.sathekge@up.ac.za
pt
70
ed
64 65 66 67
Mariza Vorster, Department of Nuclear Medicine, Steve Biko Academic Hospital, University of Pretoria, Pretoria, South Africa. Email: marizavorster@gmail.com
76
Email: dsobic2@gmail.com
Ac ce
71 72 73 74 75
Dragana Sobic Saranovic, Faculty of Medicine University of Belgrade and Center of Nuclear Medicine Clinical Center of Serbia, Belgrade, Serbia.
77 78 79
Pawana Pusuwan, Division of Nuclear Medicine, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok-noi, Bangkok 10700, Thailand
80
Email: pawana.pus@mahidol.ac.th
81
3 Page 3 of 33
82 83 84
Vera Mann, Institute of Nuclear Medicine, UCLH NHS Foundation Trust, 235 Euston Road, London NW1 2BU, UK Email: verazmann@hotmail.com
85 86
Shobhan Vinjamuri, Royal Liverpool University Hospital, Liverpool L7 8XP, UK
87
Email: Sobhan.Vinjamuri@gmail.com
Alimuddin Zumla, Center for Clinical Microbiology, Division of Infection and Immunity, University College London, and the National Institute of Health Research Biomedical Research Centre at UCL Hospitals, , London, United Kingdom. Email: a.i.zumla@gmail.com
cr
89 90 91
ip t
88
us
92
Thomas NB Pascual, Section of Nuclear Medicine and Diagnostic Imaging, Division of Human Health, Department of Nuclear Sciences and Applications, International Atomic Energy Agency, Vienna International Centre, PO Box 100, 1400 Vienna,
96
Email: T.Pascual@iaea.org
an
93 94 95
103 104 105 122
123
ed
pt
102
Jamshed Bomanji, Institute of Nuclear Medicine, UCLH NHS Foundation Trust, 235 Euston Road, London NW1 2BU, UK Email: jamshed.bomanji@nhs.net
Ac ce
98 99 100 101
M
97
4 Page 4 of 33
123
SUMMARY
125
Today TB remains a major global public health problem with 1.5 million deaths annually.
126
One in five cases of TB present as extrapulmonary TB (EPTB) posing major diagnostic and
127
management challenges. Mycobacterium tuberculosis adapts to a quiescent physiological
128
state and is notable for its complex interaction with the host, producing poorly understood
129
disease states ranging from latent infection to active clinical disease. New tools in the
130
diagnostic armamentarium are urgently required for the rapid diagnosis of TB, monitoring of
131
TB treatments, and acquisition of newer insights into pathogenesis. We review the typical
132
and atypical imaging features of extrapulmonary TB and discuss the roles of several imaging
133
modalities for the diagnosis and management of EPTB.
Ac ce
pt
ed
M
an
134
us
cr
ip t
124
5 Page 5 of 33
INTRODUCTION
135
Tuberculosis today remains a major global public health problem with 1.5 million deaths
136
annually (WHO 2014). One in five cases of TB present as extrapulmonary TB (EPTB) posing
137
major diagnostic and management challenges. Accurate diagnosis of active pulmonary
138
tuberculosis may be challenging in patients without any microbiological evidence of the
139
presence of Mycobacterium tuberculosis from sputum samples. Tuberculin skin tests or
140
serum interferon-gamma release assays can determine TB exposure in such patients but
141
cannot differentiate between active and latent disease. Culture remains the gold standard
142
but it can take upto 8-10 weeks and variable sensitivities depending on the host and sites
143
are noted. Mainly blood cultures, urine cluture and culture of other body fluids aids in the
144
diagnosis.
us
cr
ip t
134
The most frequent sites of extrapulmonary TB include lymph nodes, the peritoneum,
146
and the ileocecal, hepatosplenic, genitourinary, central nervous system (CNS), and
147
musculoskeletal regions; multisystem involvement is common.
an
145
Population groups with increased risk of TB are immunocompromised individuals
149
(AIDS, lymphoma, leukemia, post-organ transplant), diabetics, children, the elderly,
150
alcoholics, persons with a low socioeconomic status, persons with poor compliance,
151
immigrants from Third World countries, prisoners, nursing home residents, health care
152
workers, and the homeless1-3. The increase in TB has been witnessed not only in Africa and
153
Asia but also in European countries; hence TB remains an important cause of morbidity and
154
mortality worldwide4,5.
ed
pt
Ac ce
155
M
148
In this mix of risk factors multidrug-resistant (MDR) TB continues to flourish. MDR
156
TB requires prolonged administration of toxic second-line drugs, associated with higher
157
morbidity and mortality rates. Patients also remain infectious for a longer period once
158
treatment has been started. A new strain, of extensively drug-resistant (XDR) TB, is evolving;
159
this MDR strain is also resistant to second-line drugs including any fluoroquinolone and at
160
least one of three injectable drugs (capreomycin, kanamycin, and amikacin). Despite the
161
enormous burden of disease, current diagnostics are still woefully inadequate to meet
162
research and clinical needs.
163
Radiologic investigations play a crucial role in the early and correct identification of
164
extrapulmonary TB. Imaging modalities of choice are Computerised Tomography
165
(CT,lymphadenopathy and abdominal TB) and Magnetic Resonance imaging (MRI,CNS and 6 Page 6 of 33
166
musculoskeletal TB). MRI is also indicated in pediatric or pregnant patients, in whom
167
radiation is to be avoided. In addition, bone scanning is performed in skeletal TB and
168
fluorodeoxyglucose (FDG) PET-CT in assessment of disease extent and response monitoring.
169
Tuberculosis demonstrates a variety of clinical and radiologic features depending on the
170
organ site involved and has a known propensity for dissemination from its primary site.
171
Thus, TB can mimic a number of other disease entities, and it is important to be familiar
172
with the various radiologic features of TB. Herein we illustrate the imaging findings of ETB
173
and their relevance in the present scenario. Familiarity with the same helps in early
174
diagnosis, initiation of therapy and monitoring patients on treatment.
F-
cr
ip t
18
us
175
Literature review
177
A pubmed search of the relevant articles discussing role of imaging in ETB was done.
an
176
Tuberculous lymphadenopathy
179
Also known as scrofula, tuberculous lymphadenopathy is a common form of extrapulmonary
180
TB seen in endemic populations as well as immunocompromised patients in developed
181
nations. The most commonly affected lymph nodes, in decreasing order, are the cervical
182
(63%), mediastinal (27%), and axillary (8%–10%). Most cases present as unilateral cervical
183
lymphadenopathy.
184
Imaging features
185
Imaging alone cannot distinguish between the causes of lymphadenopathy.
186
Ultrasonography
187
Nodal matting with surrounding edema is seen. Doppler study may reveal increased
188
vascularity, mostly at the hilum. This feature allows differentiation from malignant lymph
189
nodes, which show peripheral vascularity6.
190
CT and MRI
191
The lymph nodes are usually matted. However, density depends on the amount of
192
caseation, which increases with time7.
193
PET-CT
194
18
195
amount of caseation . 18F FDG PET-CT has the advantage of identifying all affected lymph
Ac ce
pt
ed
M
178
F-FDG PET-CT may show peripheral uptake and central hypometabolism, depending on the
7 Page 7 of 33
node groups within a single setting and allows selection of lymph node group most suitable
197
for biopsy (Fig. 1).
cr
ip t
196
198
Fig. 1A,B.
200
Abdominal tuberculosis
201
Abdominal TB may occur directly, as in the case of primary pulmonary TB, or indirectly, via
202
spread from the primary. It generally affects the following organs:
an
us
199
Lymph nodes
204
Peritoneum
205
Ileocecal junction
206
Colon
207
Liver
208
Spleen
209
Adrenal glands
210
Solid viscera are affected to a greater extent than the gastrointestinal tract. CT is the
211
mainstay for investigation of possible abdominal TB; however, knowledge of other
212
imaging modalities, such as barium enema examination, is important to avoid
213
misdiagnosis in cases in which TB is not initially suspected.
ed pt
Ac ce
214
M
203
215
Abdominal lymphadenopathy
216
Abdominal lymphadenopathy is the most common manifestation of abdominal TB,
217
seen in 55%–66% of patients8. On CT the nodes are usually matted, appearing in groups
218
with mild fat stranding, hypoattenuating center with or without calcification. 18F-FDG PET-CT
219
shows increased metabolic activity in the nodes and plays a role in the assessment of
220
treatment response. 8 Page 8 of 33
221 222
Peritoneal tuberculosis
223
Peritoneal TB affects one-third of patients and is oneof the most common manifestations of
224
abdominal TB. Subdivision, into wet, fibrotic, and dry types has been proposed9. On imaging,
225
there may be significant overlap between the three. Wet type: manifests in more than 90% of patients, has high protein and cellular
227
content, leading to high-attenuating pockets of loculated fluid or free ascites. The
228
Hounsfield unit (HU) ranges from 20 to 45.
ip t
226
Dry type: cake-like omentum with fibrous adhesions and mesenteric thickening.
230
Fibrotic type: presents as omental or mesenteric masses.
us
231
cr
229
The main imaging differential diagnoses are malignancy and peritoneal carcinomatosis10.
an
232 233 234
Gastrointestinal tract tuberculosis
236
Due to the abundance of lymphoid tissue, the ileocecal junction (90%) is one of the most
237
common sites of involvement in the bowel8,9. The presentation may be ulcerative,
238
hypertrophic, or ulcerohypertrophic11,12.
239
Imaging features
240
Barium studies
241
In early stages, narrowing of the terminal ileum, thickening and gaping of the ileocecal
242
valve, and thickening and hypermotility of the cecum are noted. In chronic stages, the
243
ileocecal valve appears fixed, rigid, and incompetent, while the cecum appears shrunken in
244
size. In later stages a “pulled-up” cecum is usually noted.
245
CT
246
On CT circumferential wall thickening of the terminal ileum and cecum is noted, usually in
247
association with mesenteric lymphadenopathy. The differential diagnosis includes Crohn’s
248
disease, carcinoma, and lymphomatous involvement.
249
Involvement of the esophagus, stomach, duodenum, and small bowel is still rare.
250
Esophageal TB is mainly from the carinal lymph nodes. Small bowel TB may present as
251
mucosal thickening. The antrum and distal body are the most commonly affected sites in
252
the stomach. The presence of a fistula or a sinus confirms the diagnosis.
Ac ce
pt
ed
M
235
9 Page 9 of 33
Hepatosplenic tuberculosis
254
Hepatosplenic TB may present as miliary or macronodular involvement. The lesions are
255
hypoattenuating on CT and may show peripheral postcontrast enhancement. The most
256
common route of involvement is hematogenous either through hepatic artery in military TB
257
or through portal vein fromgastrointestinal lesions. Macronodular involvement is less
258
frequent and is manifested by single or multiple focal density lesions with or without
259
peripheral rim enhancement.
260
On MRI, macronodular lesions appear hypointense on T1-weighted images and hypoto
261
hyperintense on T2-weighted images, with thin peripheral and/or internal septal
262
enhancement.
263
Differential diagnosis includes fungal infections, sarcoidosis, lymphoma, and, rarely,
264
metastasis.
265
Adrenal tuberculosis
266
The adrenal glands are the most common endocrine glands involved by TB. The spread is
267
predominantly via the hematogenous route and may be unilateral or bilateral, with central
268
areas of caseation. The involvement of adrenal cortex, may lead to primary adrenal
269
insufficiency and where
270
addisonian crisis may ensue13.
271
In early stages, smooth enlargement of the gland with low-density areas andrelative central
272
hypoenhancement is noted on CT14. In later stages and/or in previously treated patients,
273
gland atrophy with punctate, localized, or diffuse calcification is observed.
274
The MRI features are analogous to the CT appearances except for limitations when
275
calcification is present. 18F-FDG PET-CT shows increased metabolic activity in adrenals in TB
276
or any infection. Often this may be an incidental finding on PET-CT done for another
277
diagnosis. The gland may show diffuse or patchy uptake on 18F-FDG images.
278
Genitourinary tuberculosis
279
Tuberculosis may involve the genitourinary tract as a secondary site following
280
hematogenous dissemination from the lungs15.
M
an
us
cr
ip t
253
Ac ce
pt
ed
more than 90% of the cortex is involved, a life-threatening
281 282
Renal tuberculosis
10 Page 10 of 33
Tuberculosis at these sites accounts for 15%–20% of cases of extrapulmonary TB16.
284
Routinely, two morphological appearances are seen: pyelonephritis or a pseudotumoral
285
type presenting as single or multiple nodules.
286
The collecting system is involved in isolation or due to contiguous spread from the
287
parenchyma. In early stages, papillary necrosis resulting in uneven caliectasis is noted.
288
Hydronephrosis and multifocal strictures with mural thickening and enhancement are
289
observed in progressive disease. Progressive hydronephrosis and parenchymal thinning with
290
dystrophic calcification are noted in end-stage disease.
291
Imaging features
292
Plain radiography
293
On plain radiographs, foci of calcification are noted in 25%–45% of patients17. Triangular
294
ring-like calcification in the collecting system is observed in cases of papillary necrosis.
295
Amorphous focal ground glass-like calcification (putty kidney) is seen in end-stage disease18.
296
Intravenous urography
297
Plain film intravenous urography is quite sensitive in detecting renal TB19: Only 10%–15% of
298
those affected have normal imaging. A range of findings may be observed, including
299
parenchymal scars (50%),
300
caliectasis, phantom calyx, and hydronephrosis. Lower urinary tract signs include the “Kerr
301
kink”, which occurs due to abrupt narrowing at the pelviureteric junction20.
302
Ultrasonography
303
In early-stage disease, ultrasonography may show an irregular cortical outline with
304
calcification. As the disease progresses, papillary destruction with echogenic masses and
305
distorted renal parenchyma can be observed. In end-stage disease, heavy dystrophic
306
calcification with a small shrunken kidney is noted.
307
Ultrasonography is less sensitive in detecting isoechoic masses and small calcifications and
308
in identifying small cavities communicating with the collecting system.
309
CT and MRI
310
CT intravenous pyelography is most sensitive in identifying all manifestations of renal TB.
311
Depending on the site of the stricture, various patterns of hydronephrosis may be seen,
312
including focal caliectasis, caliectasis without pelvic dilatation, and generalized
313
hydronephrosis. Other common findings include parenchymal scarring and low-attenuation
M
an
us
cr
ip t
283
Ac ce
pt
ed
moth-eaten calyces due to necrotizingpapillitis, irregular
11 Page 11 of 33
314
parenchymal lesions. CT is also useful in depicting the extension of disease into the
315
extrarenal space21,22.
316
The radiologic differential diagnosis of renal TB includes other causes of papillary necrosis,
318
transitional cell carcinoma, and other infections. 18F-FDG PET-CT may be used to evaluate
319
renal masses (Fig. 2), to identify latent or active TB in the lung, or to monitor therapy.
us
cr
ip t
317
320
Fig. 2A,B
322
Ureteric Tuberculosis
323
Imaging features
324
Intravenous Urography
325
In the chronic state, beaded areas due to alternate strictures and dilatation are noted.
326
CT
327
Ureteral wall thickening is observed in the acute setting. In chronic disease, strictures and
328
shortening of the ureter, leading to pipe stem ureter, are noted.
329
Urinary bladder tuberculosis
330
Urinary bladder involvement is secondary to descending spread of infection along the
331
urinary tract22.An irregular wall with a small capacity bladder is noted. Fibrotic changes at
332
the ureteric orifices lead to vesicoureteric reflux and hydroureteronephrosis23.
M
ed
pt
Ac ce
333
an
321
334
Female genital organs
335
Involvement of the genital organs occur in 1.5% of females affected with TB. Spread may be
336
via the hematogenous or the lymphatic route. On hysterosalpingography, obstruction is
337
usually noted at the junction of the isthmus and the ampulla24,25. A beaded appearance is
338
seen due to multiple constrictions. A normal uterine cavity may be observed in more than
339
50% of cases. A further possible presentation is as an irregular filling defect with uterine
12 Page 12 of 33
340
synechiae and shrunken cavity (3%–18% of cases).Lesions may show uptake on 18F-FDG PET-
341
CT (Fig. 3).
M
an
us
cr
ip t
342
343
Fig. 3.
ed
344 345
Male genital organs
347
Involvement of the genital organs in males is generally confined to the seminal vesicles or
348
prostate gland, with occasional calcification (10% of cases). The testes and epididymides are
349
rarely involved. Hypoattenuating lesions are noted on contrast-enhanced CT, likely
350
representing foci of caseous necrosis. Nontuberculous pyogenic prostatic abscesses have a
351
similar CT appearance22. The spread is hematogenous and self-limiting. Ultrasonography
352
shows focal or diffuse areas of decreased echogenicity; however, these findings are very
353
nonspecific23,26.
Ac ce
pt
346
354 355
Musculoskeletal tuberculosis
356
Musculoskeletal TB accounts for about 3% of all TB infections. The main route of spread is
357
hematogenous, from lungs, or via activation of dormant infection in bone or joint post
358
trauma27. Cases of musculoskeletal TB are usually subclassified as tubercular spondylitis 13 Page 13 of 33
359
(50%) (popularly called Potts' spine), peripheral tuberculous arthritis (60%), osteomyelitis
360
(38%), and soft tissue TB, including tenosynovitis and bursitis28-30.
361
Tubercular spondylitis
363
The disease spread is via the venous plexus of Batson. The most commonly affected
364
vertebrae are the lower thoracic and upper lumbar. The vertebral body is involved to a
365
greater extent than the posterior elements, and the classical presentation is involvement of
366
two or more contiguous vertebrae with or without paravertebral abscess. The presence of
367
calcification, which may sometimes be absent, almost confirms the diagnosis. In cases of
368
anterior subligamentous involvement, the infection spreads inferiorly or superiorly without
369
vertebral disk involvement.
us
cr
ip t
362
370
an
371
Imaging features
373
Plain radiography
374
Potential early changes include irregular end plates and a decrease in vertebral height.
375
Sharp angulation or gibbus deformity is noted, with anterior wedging or collapse.
376
Displacement of paraspinal lines suggestive of psoas involvement may be noted. The
377
calcified psoas is suggestive of an abscess.
378
Spinal TB might lead to vertebra plana where there is a reduction in anterior and posterior
379
height, preserved intervertebral disk andsome forms of vertebral end plate change.
Ac ce
pt
ed
M
372
380 381
Ultrasonography
382
Ultrasonography is usually helpful in identifying iliopsoas abscess and its percutaneous
383
drainage.
384 385
CT
386
Cross-sectional imaging is required to better establish the extent of vertebral involvement
387
and the possible presence of a paravertebral abscess.
388 389
MRI
14 Page 14 of 33
MRI is the gold standard investigation for tubercular spondylitis. MRI helps to identify the
391
presence of an epidural component and cord compression. An early finding is focal T2
392
hyperintense and T1 hypointense bone marrow edema in the anterior part of vertebral body
393
adjacent to endplates, with patchy postcontrast enhancement. An abnormal T2
394
hyperintense signal is noted in the involved disk space, with reduced height. Multifocal TB,
395
compression of the spinal cord, abnormal T2 hyperintense signal in the spinal cord, and
396
neural foraminal and neural compromise secondary to epidural collections are well
397
demonstrated on MRI. MRI may also demonstrate the complete extent of an iliopsoas or
398
paraspinal abscess. Small foci of involvement of posterior elements are better observed on
399
MRI than CT31-33.
us
cr
ip t
390
400 401
Bone scintigraphy
402
99m
403
be used to rule out metastasis suggested by the involvement of multiple contiguous
404
vertebrae (Fig. 4).
M
an
Tc-Methylene diphosphonate bone scan may identify multifocal sites and can sometimes
406
Fig. 4.
407
Ac ce
pt
ed
405
408
18
F-FDG PET-CT
409
18
F-FDG PET-CT may show increased uptake in tubercular spondylitis, with identification of
410
multiple sites, and offer further help in response monitoring34,35 (Figs. 5, 6).
15 Page 15 of 33
ip t cr Fig. 5A–F.
413 415
Fig. 6A–F
Ac ce
414
pt
ed
M
an
412
us
411
416
Tubercular arthritis
417
Tubercular arthritis is the most common extra-axial form of musculoskeletal TB. In 90% of
418
cases, it is monoarticular, commonly affecting large weight-bearing joints such as the hip
419
and knee36,37. Less commonly it involves the shoulder, elbow, and sacroiliac joints.
420
Periarticular osteoporosis, peripherally located osseous erosion, and progressive decrease in
421
the joint space suggest the diagnosis of TB and are popularly referred to as the “Phemister
422
triad”. In later stages, fibrosingankylosis ensues37-39. Atrophic changes in bones may occur
423
and lead to atrophic arthropathy, especially in the shoulder joint.
424 425
Imaging features 16 Page 16 of 33
426
Ultrasonography
427
Ultrasonography mainly helps in identifying joint effusion, although the appearances are
428
nonspecific.
429
CT
431
CT helps to establish the degree of bone destruction. Sequestrum or sinus formation can be
432
demonstrated on postcontrast scan.
ip t
430
433
MRI
435
Lesions are usually T1 hyperintense and T2 hypointense and show brilliant post-gadolinium
436
enhancement which is a result of blood degradation products and inflammation. Sinus tracts
437
appear as linear T2 hyperintensity with marginal “tram track enhancement”28,37.
us
cr
434
an
438
Tubercular osteomyelitis
440
Tubercular osteomyelitis is most commonly seen in bones of the extremities (femur, tibia),
441
including the small bones of the hands and feet (Figs. 7, 8), often involving the epiphyses. In
442
children, metaphyseal foci can involve the growth plate, a feature that differentiates TB
443
from pyogenic infection40.
444
eburnation and periostitis are observed.
Radiologically, foci of osteolysis with varying degrees of
pt
445
ed
M
439
Tubercular dactylitis
447
Tuberculous dactylitis, in which there is painless involvement of the short tubular bones of
448
the hands and feet, is more common in children. At radiography, pronounced fusiform soft
449
tissue swelling with or without periostitis is the most common finding41,42.
Ac ce
446
17 Page 17 of 33
ip t cr us
450 451
Fig. 7.
Ac ce
pt
ed
M
an
452
453 454
Fig. 8.
455 456
Central nervous system tuberculosis (CNS TB) 18 Page 18 of 33
457
The spread is either hematogenous, or by direct extension from local infection, such as
458
tuberculous otomastoiditis. CNS TB accounts for 1% of all TB and 10%–15% of
459
extrapulmonary TB. It is a leading cause of morbidity and mortality in endemic regions43,44.
460
463
-
Tubercular leptomeningitis
464
-
Tubercular pachymeningitis
Intra-axial
cr
465
ip t
Extra-axial
466
-
Tuberculoma
467
-
Focal cerebritis
468
-
Tubercular abscess
469
-
Tubercular rhomboencephalitis
470
-
Tubercular encephalopathy
M
471
us
462
Manifestations of cranial TB include:
an
461
Tubercular leptomeningitis
473
Tubercular leptomeningitis (TBM) is more common than pachymeningitis. It presents with
474
thick tuberculous exudate in the base of brain in the subarachnoid space, the most common
475
location being the interpeduncular fossa. Extension to the surface of the cerebral
476
hemispheres is rare.
477
Cerebrospinal fluid (CSF) flow may be disrupted, leading to obstructive hydrocephalus or
478
communicating hydrocephalus due to obstruction in the basal cisterns. Ischemic infarcts due
479
to arteritis are also noted. In addition, involvement of the cranial nerves may be observed,
480
with the second, third, fourth, and seventh most frequently affected45-47.
481
On MRI, abnormal meningeal enhancement is noted. The magnetization transfer (MT)
482
technique is reported to be superior in differentiating TBM from other causes of meningitis.
483
Meninges appear hyperintense on precontrast T1-weighted MT images and enhance further
484
on postcontrast T1-weighted MT images. The MT ratio in TBM is significantly higher than in
485
viral meningitis, while fungal and pyogenic meningitis show a higher MT ratio compared
486
with TBM48.
Ac ce
pt
ed
472
487 488
Tubercular pachymeningitis 19 Page 19 of 33
489
Tubercular pachymeningitis is rare and is characterized by plaque-like regions of
490
pachymeningeal enhancement that appear hyperdense on plain CT scan, isointense to brain
491
on T1-weighted imaging, and isointense to hypointense on T2-weighted imaging.
492
Homogeneous post-contrast scan enhancement is noted.
493
Tuberculoma
495
Lesions may be solitary, multiple, or miliary. The most commonly affected areas are the
496
frontal and parietal lobes. Tuberculomas account for 15%–50% of space-occupying lesions in
497
endemic areas.
498
Imaging features
499
CT
500
The classical presentation is homogeneous ring-enhancing lesions with irregular walls of
501
varying thickness. One-third of patients demonstrate the “target sign” (i.e., central
502
calcification or punctate enhancement with surrounding hypoattenuation and ring
503
enhancement)45.
M
an
us
cr
ip t
494
504
MRI
506
Appearances on MRI depend on whether the tuberculoma is caseating or noncaseating.
507
Noncaseating tuberculomas are hypointense on T1-weighted and hyperintense on T2-
508
weighted images, with homogeneous post-contrast enhancement. Caseating granulomas
509
are isointense to hypointense on both T1- and T2-weighted images, with peripheral
510
postcontrast enhancement. Caseating
511
owing to liquefaction. Associated TBM may be seen. In miliary TB, tiny 2- to 5-mm T2
512
hyperintense disk enhancing tuberculomas are seen with TBM. They are better visualized on
513
MT spin echo T1-weighted images49. MR spectroscopy is promising in the specific diagnosis
514
of tuberculomas. A large lipid lactate peak at 1.3 ppm is characteristic, with associated
515
reduced N-acetyl aspartate and/or slightly increased choline levels.
Ac ce
pt
ed
505
granuloma may show central T2 hyperintensity
516 517
18
518
(Fig 9).
F FDG PET-CT and MRI might be complementary to each other in identifying the lesions
20 Page 20 of 33
519
Fig 9.
521
Tubercular abscess
522
Tubercular abscess accounts for 4%–7% of cases in the endemic region. Presentation is as a
523
large solitary lesion, which may be multiloculated, with surrounding vasogenic edema and
524
mass effect. Such abscesses have pus-filled centers, vascular granulation tissue, and absence
525
of epithelioid granulomatous reaction. The causative organism may be isolated from the
526
pus, in contrast to tuberculomas.
an
us
cr
ip t
520
527
The lesion may show central low intensity on T1-weighted images and peripheral low
529
intensity due to vasogenic edema. Diffusion-weighted imaging reveals restricted diffusion
530
with low apparent diffusion coefficient values. On imaging, pyogenic and fungal abscesses
531
may mimic tuberculous abscess. Tuberculous abscess shows a large lipid lactate peak at 1.3
532
ppm on MR spectroscopy owing to the presence of mycolic acid within the mycobacterial
533
walls, which represents a distinguishing feature from pyogenic abscess50.
534
pt
ed
M
528
Rhomboencephalitis
536
Rhomboencephalitis is a particular form of neurotuberculosis affecting the hind brain. The
537
most common manifestation is tuberculoma.
538
Encephalopathy
539
Encephalopathy in the context of TB is most commonly observed in children and infants
540
with pulmonary TB. The postulated mechanism is a delayed type IV hypersensitivity reaction
541
initiated by a tuberculous protein which leads to extensive damage of white matter with
542
infrequent perivascular demyelination. Imaging shows extensive unilateral or bilateral brain
543
edema51.
Ac ce
535
544 545
Spinal and meningeal involvement 21 Page 21 of 33
Spinal TB (Fig. 10) commonly manifests as TBM and rarely as intramedullary tuberculoma.
547
MRI is the modality of choice for spinal TB assessment. Spinal TBM manifests as linear
548
enhancing exudates along the spinal cord in the subarachnoid spaces and clumping of cauda
549
equina nerve roots34.
an
us
cr
ip t
546
M
550 551
Fig. 10.
553
ed
552
Tubercular otomastoiditis
555
Tubercular otomastoiditis, which occurs acutely secondary to tuberculosis infection, is more
556
frequently observed in immunocompromised patients. It may present with painless chronic
557
otorrhea with an intact tympanic membrane or as pain, purulent discharge, and ossicular
558
erosion. There may be associated cervical lymph nodal involvement in the interparotid,
559
upper cervical, and preauricular regions. Pachymeningeal involvement with potential dural
560
sinus thrombosis is also sometimes seen.
Ac ce
561
pt
554
562 563
Tubercular mastitis
564
Tubercular mastitis is a rare occurrence, although the incidence has been rising (0.1%–3%)
565
in endemic areas like Africa and India52. The first case was reported in 1829 by Sir Ashley
566
Cooper, who referred to it as “scrofulous swelling of the bosom”53. The significance of breast
567
TB lies in the fact that its masquerades the symptoms of breast cancer and inflammatory 22 Page 22 of 33
disease of the breast. It may present in nodular form or as multifocal disease. 53Radiological
569
imaging is not diagnostic as there is significant overlap with other pathologies. Breast
570
ultrasonography may show a hypoechoic mass or focal or sectorial duct ectasia. Caseating
571
granulomas in a tissue sample are diagnostic.
572
Cardiac tuberculosis
573
Cardiac TB is a rare infection involving the cardiac muscles that is seen in 1%–2% of patients
574
with pulmonary TB54,55. There is predominantly pericardial and myocardial involvement, and
575
endocardial spread may occur from the myocardium.
ip t
568
cr
576
Imaging features
578
Plain radiography
579
The radiographic appearance may be normal in the early stages while pericardial
580
calcification may be evident in later stages.
581
CT and MRI
582
CT may reveal pericardial effusion, thickening, or calcification in the chronic stages. On
583
cardiac MRI, T1-weighted images may show a nodular lesion which appears isointense to
584
slightly hyperintense. On T2-weighted images the lesion appears isointense, with mild
585
enhancement post gadolinium.
ed
M
an
us
577
586
pt
587
Role of PET-CT: challenges and limitations
589
FDG is a non-physiological glucose analog that undergoes metabolism by the same
590
physiological processes as glucose, including being taken up by cell surface transporters
591
(mainly the glucose transporter-1, GLUT-1) and transformed by the rate-limiting glycolytic
592
enzyme, hexokinase, into FDG-6-phosphate. An interesting early observation by Kubota and
593
co-workers was that a substantial component of 18F-FDG uptake in tumor tissue is a result of
594
activity localizing to peritumoral inflammatory cells, such as macrophages, which
595
demonstrate greater 18F-FDG uptake than tumor cells. Multiple mechanistic similarities are
596
now recognized between inflammatory and malignant cells in terms of the underlying
597
metabolic pathways56. It is this differential increase in tissue glycolysis in inflamed tissue, as
598
opposed to normal cells, that forms the pathophysiological basis for use of 18F-FDG PET-CT
599
in TB.
Ac ce
588
23 Page 23 of 33
600
18
601
TB. Tubercular lymphadenopathy shows high-grade metabolism, and
602
therefore help in selecting nodes suitable for biopsy based on metabolic uptake/SUVs.
603
Moreover, PET-CT is more sensitive than structural imaging methods in detecting lesions.
604
Apart from assisting in selection of the site for biopsy, PET-CT may play a significant role in
605
monitoring response to treatment: its ability to detect changes in metabolic uptake means
606
that it may be considered a specific complementary tool to structural imaging for this
607
purpose57. Refining of imaging techniques like dual time point imaging may further improve
608
the detection of disease60 (Fig 11).
609
Repeat biopsy in bone TB is not advised, and in this context metabolic uptake on
610
PET-CT may be taken into consideration. Indeed,
611
invasive modality for assessment of treatment response and disease activity. In patients
612
with increase metabolic uptake on treatment, most likely suggest disease progression/disease
613
burden. In such cases patient might benefit from prolongation of treatment duration/changing
614
drug regime, thus individualising treatment protocol57-59.
F-FDG PET-CT is useful in identifying the extent of disease in patients with extrapulmonary F-FDG PET-CT may
F-FDG
F-FDG PET-CT represents an ideal non-
M
an
18
18
us
cr
ip t
18
615
617 618
Ac ce
pt
ed
616
Fig. 11.
619 620
TB associated with HIV infection
621
The immunocompromised status associated with HIV infection reduces the threshold for
622
reactivation of dormant diseases such as TB. In such patients treatment of TB goes hand in
623
hand with HIV treatment, and can be similarly followed up with serial PET-CT scans. 24 Page 24 of 33
However, frequent monitoring is mandatory in these cases as faster conversion of bacteria
625
into resistant forms is often seen.60
626
With the increase in XDR and MDR TB and HIV infection, an individualized therapeutic
627
approach is gaining greater importance in this chronic inflammatory disease, which requires
628
a sensitive diagnostic method for assessment of not only treatment efficacy but also initial
629
disease spread as well as for guidance of biopsy when equivocal findings are observed.
630
Patients with HIV and TB are prone to developing certain concomitant malignant lesions. As
631
mentioned previously, the major limitation of PET in this context is that it cannot adequately
632
differentiate etiology of various lesions/lymph nodes.
633
Table 1: Comparison of CT, MRI and 18F FDG PET-CT in diagnosing EPTB.
us
cr
ip t
624
Magnetic resonance imaging
18FF FDG PET/CT
Anatomy
Yes
Yes
Yes
Functionality
No
No
No
Radiation burden
Yes
No
Yes
Treatment response
Yes (Size based)
Yes (Size based)
Both anatomical and functional
Protocol
Regional
Regional
Whole body image in single setting
CNS ETB
Inferior to MR
Superior image quality
Less lesions detected depending on resolution or If the patient is on steroids
Musculoskeletal TB
Inferior to MR
Modality of choice
Assessing disease burden and response assessment
Abdominal TB and lymphadenopathy
Modality of choice
-
Response assessment and disease burden.
Ac ce
pt
ed
M
an
Computerised tomography
634
25 Page 25 of 33
Conclusion
635
Radiological investigations continue to play an important role in the evaluation of various
636
manifestations, sites of infection and disease burden in patients with TB, especially
637
extrapulmonary TB keeping in mind that TB can mimic a number of other disease entities.
638
The authors understand that biopsy and culture studies stay as the Gold Standard for
639
diagnosing TB. FDG PET-CT provides a visual metabolic map, complementary to
640
conventional imaging techniques. Also, whole-body PET-CT imaging may shorten the time
641
period involved in the assessing of disease burden and may play an important role in decision
642
making regarding duration of therapy, especially in developing countries in cases with
643
extrapulmonary TB. More precise characterization of the role of PET-CT in clinical management
644
decision making awaits further studies of larger numbers of patients.
an
us
cr
ip t
634
645
Acknowledgements:
647
All authors are grateful to the International Atomic Energy Agency for their support of the
648
Coordinated Research Project (CRP) E15021
649
pt
Conflict of Interest: None
Ac ce
650
ed
M
646
26 Page 26 of 33
651
1. Global Tuberculosis Report 2015: 20th Edition, World Health Organization. ISBN 9789241565059
654
2. Maclean KA, Becker AK, Chang SD, Harris AC. Extrapulmonary tuberculosis: imaging features beyond the chest. Can AssocRadiol J 2013;64:319–24.
656 657
3. Rafique A. The spectrum of tuberculosis presenting at a London district general hospital. West Lond Med J 2009;1(No 4):19–38.
658 659
4. Alrajhi AA, Al-Barrak AM. Extrapulmonary tuberculosis, epidemiology and patterns in Saudi Arabia. Saudi Med J 2002;23:503–8.
660 661 662
ip t
655
cr
653
References
5.
us
652
ZumlaA. The white plague returns to LondonWithavengeance.Lancet 2011;377:10–1.
6. Ahuja A, Ying M, Yuen YH, Metreweli C. Power Doppler sonography to differentiate
664
tuberculous cervical lymphadenopathy from nasopharyngeal carcinoma. AJNR Am J
665
Neuroradiol. 2001;22:735–40.
669 670 671
M
ed
668
Williams & Wilkins; 2006.
8. Leder RA, Low VH. Tuberculosis of the abdomen. RadiolClin North Am 1995;33:691– 705.
9. Suri S, Gupta S, Suri R. Computed tomography in abdominal tuberculosis. Br J Radiol 1999;72:92–8.
pt
667
7. Lee JK. Computed body tomography with MRI correlation. Philadelphia: Lippincott
Ac ce
666
an
663
672
10. Takalkar AM, Bruno GL, Reddy M, Lilien DL. Intense FDG activity in peritoneal
673
tuberculosis mimics peritoneal carcinomatosis. ClinNucl Med 2007;32:244–6.
674 675
11. Thoeni R, Margulis A. Gastrointestinal tuberculosis. SeminRoentgenol 1979; 14:283– 94.
676
12. Nakano H, Jaramillo E, Watanabe M, Miyachi I, Takahama K, Itoh M. Intestinal
677
tuberculosis: findings on double contrast barium enema. GastrointestRadiol
678
1992;17:108–14.
679
13. Huang YC, Tang YL, Zhang XM, Zeng NL, Li R, Chen TW. Evaluation of primary adrenal
680
insufficiency secondary to tuberculosis adrenalitis with computed tomography and
681
magnetic resonance imaging: Current status. World J Radiol 2015;7: 336–42.
27 Page 27 of 33
682
14. Buxi TB, Vohra RB, Sujatha, Byotra SP, Mukherji S, Daniel M. CT enlargement due to
683
tuberculosis: a review of literature with five new cases. Clin Imaging 1992;16:102–8.
684
15. Pasternak MS, Rubin RH. Urinary tract tuberculosis. In: Schrier RW, ed. Diseases of
685
the kidney and urinary tract. 7th edition. Philadelphia: Lippincott Williams & Wilkins;
686
2001; p. 1017–37.
688
16. Burrill J, Williams CJ, Bain G, Conder G, Hine AL, Misra RR. Tuberculosis: a radiologic
ip t
687
review. Radiographics 2007;27:1255–73.
17. Kollins SA, Hartman GW, Carr DT,Segura JW, Hattery RR. Roentgenographic findings
690
in urinary tract tuberculosis: a 10 year review. Am J Roentgenol Radium TherNucl
691
Med 1974;121:487–99.
us
cr
689
18. Davidson AJ, Hartman DS, Choyke PL, Wagner BJ. Parenchymal disease with normal
693
size and contour. In: Davidson AJ, editor. Davidson’s radiology of the kidney and
694
genitourinary tract. 3rd edition. Philadelphia: Saunders; 1999; p. 327–58.
699 700 701 702 703 704 705 706 707
M
698
20. Berry M, editor. Diagnostic radiology, urogenital imaging. New Delhi: Jaypee Brothers Publishers; 2003.
ed
697
94.
21. Wang LJ, Wong YC, Chen CJ, Lim KE. CT features of genitourinary tuberculosis. J Comput Assist Tomogr 1997;21:254–8.
22. Harisinghani MG, McLoud TC, Shepard JA, Ko JP, Shroff MM, Mueller PR.
pt
696
19. Kenney PJ. Imaging of chronic renal infections. AJR Am J Roentgenol 1990;155:485–
Tuberculosis from head to toe. Radiographics 2000;20:449–70.
Ac ce
695
an
692
23. Kim SH. Genitourinary tuberculosis. In: Pollack HM, Dyer R, McClennan BL, editors. Clinical urography. 2nd edition. Philadelphia: Saunders; 2000, p. 1193–228.
24. YY Jung, Kim JK, Cho KS. Genitourinary tuberculosis: comprehensive cross-sectional imaging. AJR Am J Roentgenol 2005;184:143–50.
25. Sharma JB, Pushpraj M, Roy KK, Neyaz Z, Gupta N, Jain SK, et al.
708
Hysterosalpingographic findings in infertile women with genital tuberculosis. Int J
709
GynaecolObstet 2008;101:150–5.
710
26. Michaelides M, Sotiriadis C, Konstantinou D, Pervana S, Tsitouridis I. Tuberculous
711
orchitis US and MRI findings: Correlation with histopathological
712
findings.Hippokratia. 2010;14:297–9.
28 Page 28 of 33
713
27. Andronikou S, Bindapersad M, Govender N, Waner JI, Segwe A, Palliam S, et al.
714
Musculoskeletal tuberculosis - imaging using low-end and advanced modalities for
715
developing and developed countries. ActaRadiol 2011;52:430–41.
716
28. Suh JS, Lee JD, Cho JH, Kim MJ, Han DY, Cho NH. MR imaging of tuberculous arthritis: clinical and experimental studies. J MagnReson Imaging 1996;6:185–9.
718
29. Jaovisidha S, Chen C, Ryu KN, Siriwongpairat P, Pekanan P, Sartoris DJ, et al.
ip t
717
719
Tuberculous tenosynovitis and bursitis: imaging findings in 21cases. Radiology
720
1996;201:507–13.
725 726 727 728 729 730
cr
us
724
31. Lee KY. Comparison of pyogenic spondylitis and tuberculous spondylitis. Asian Spine J 2014;8:216–23.
32. Sinan T, Al-Khawari H, Ismail M, Ben-Nakhi A, Sheikh M. Spinal tuberculosis: CT and
an
723
IntOrthop 1986;10:201–7.
MRI feature. Ann Saudi Med 2004;24:437–41.
33. Raut AA, Naphade PS, Ramakantan R. Imaging spectrum of extrathoracic
M
722
30. Martini M, Adjrad A, Boudjemaa A. Tuberculous osteomyelitis: a review of 125 cases.
tuberculosis. RadiolClin North Am. 2016;54:475–501. 34. Bomanji JB, Gupta N, Gulati P, Das CJ. Imaging in tuberculosis. Cold Spring
ed
721
HarbPerspect Med 2015;5: a017814.
35. Skoura E, Zumla A, Bomanji J. Imaging in tuberculosis. Int J Infect Dis 2015;32:87–93.
732
36. De Backer AI, Mortelé KJ, Vanhoenacker FM, Parizel PM. Imaging of extraspinal musculoskeletal tuberculosis. Eur J Radiol 2006;57:119–30.
Ac ce
733
pt
731
734
37. De Backer AI, Vanhoenacker FM, Sanghvi DA. Imaging features of extraaxialxaio
735
musculoskeletal tuberculosis. Indian J Radiol Imaging 2009;19(3):176–86.
736
38. Dhillon MS, Sharma S, Gill SS, Naqi ON. Tuberculosis of bones and joints of the foot:
737
an analysis of 22 cases. Foot Ankle 1993;14:505–13.
738
39. Hugosson C, Nyman RS, Brismar J, Larsson SG, Lindahl S, Lundstedt C. Imaging of
739
tuberculosis. V. Peripheral osteoarticular and soft-tissue tuberculosis. ActaRadiol
740
1996;37:512–6.
741 742
40. Lee AS, Campbell JA, Hoffman EB. Tuberculosis of the knee in children. J Bone Joint Surg Br 1995;77:313–8.
29 Page 29 of 33
743
41. Bhaskar, Khonglah T, Bareh J. Tuberculous dactylitis (spina ventosa) with
744
concomitant ipsilateral axillary scrofuloderma in an immunocompetent child: a rare
745
presentation of skeletal tuberculosis. Adv Biomed Res 2013;2:29.
746
42. Singhal S, Arbart A, Lanjewar A, Ranjan R. Tuberculous dactylitis - a rare manifestation of adult skeletal tuberculosis. Indian J Tuberc 2005;52:218–9.
748
43. Garg RK. Classic diseases revisited: tuberculosis of the central nervous system.
754 755 756 757 758 759 760 761
cr
2005;55:188–92.
46. de Castro CC, de Barros NG, Campos ZM, Cerri GG. CT scans of cranial tuberculosis. RadiolClin North Am 1995;33:753–69.
47. Jinkins JR, Gupta R, Chang KH, Rodriguez-Carbajal J. MR imaging of central nervous system tuberculosis. RadiolClin North Am 1995;33:771–86. 48. Gupta RK, Kathuria MK, Pradhan S. Magnetization transfer MR imaging in CNS tuberculosis. AJNR Am J Neuroradiol 1999;20:867–75. 49. Gupta RK, Kumar S. Central nervous system tuberculosis. Neuroimaging Clin N Am 2011; 21(4):795–814.
50. Luthra G, Parihar A, Nath K, Jaiswal S, Prasad KN, Husain N, et al. Comparative
763
evaluation of fungal, tubercular, and pyogenic brain abscesses with conventional and
764
Ac ce
762
us
753
45. Morgado C, Ruivo N. Imaging meningo-encephalic tuberculosis. Eur J Radiol
an
752
Lancet Neurol 2005;4:160–70.
M
751
44. Thwaites GE, Tran TH. Tuberculous meningitis: many questions, too few answers.
ed
750
Postgrad Med J 1999;75:133–40.
pt
749
ip t
747
765
diffusion MR imaging and proton MR spectroscopy. AJNR Am J Neuroradiol 2007;28:1332–8.
766
51. Patkar D, Narang J, Yanamandala R, Lawande M, Shah GV. Central nervous system
767
tuberculosis: pathophysiology and imaging findings. Neuroimaging Clin N Am
768 769 770 771
2012;22:677–705.
52. Cooper A. Illustrations of the diseases of the breast. Part I. London: Longman, Rees, Orme, Brown and Green; 1829, p. 73. 53. Al-Marri MR, Almosleh A, Almoslmani Y. Primary tuberculosis of the breast in Qatar:
772
ten year experience and review of the literature. Eur J Surg 2000;166:687–90.
773
54. Horn H, Saphir O. The involvement of myocardium in tuberculosis: a review of
774
literature and a report of three cases. Am Rev Tuber 1935;32:492–504. 30 Page 30 of 33
775 776
55. Agarwal N, Sharma SK. Concomitant endobronchial tuberculosis, myocarditis and congestive cardiac failure. Indian J Tuberc 2000;47:169–70. 56. Kubota R, Kubota K, Yamada S, Tada M, Ido T, Tamahashi N. Microautoradiographic
778
study for the differentiation of intratumoral macrophages, granulation tissues and
779
cancer cells by the dynamics of fluorine-18-fluorodeoxyglucose uptake. J Nucl Med
780
1994;35:104–12.
ip t
777
57. Stelzmueller I, Huber H, Wunn R, Hodolic M, Mandl M, Lamprecht B, et al. 18F-
782
FDGPET/CT in the initial assessment and for follow-up in patients with tuberculosis.
783
ClinNucl Med 2016;41:e187–94.
785
58. Vorster M, Sathekge MM, Bomanji J. Advances in imaging of tuberculosis: the role of
us
784
cr
781
¹⁸F-FDG PET and PET/CT. CurrOpinPulm Med 2014;20:287–93.
59. Gambhir S, Kumar M, Ravina M, Bhoi S K et al. Role of 18FDG PET in demonstrating
787
disease burden in patients with tubercular meningitis. J. Neurol. Sci. 2016;370:196-
788
200.
789
60. Sathekge M, Maes A, Van de Wiele C. FDG PET imaging in HIV infection and
790
tuberculosis. SeminNucl Med 2013;43:349–66.
M
an
786
61. Kim DW, Kim CG. Dual-time point positron emission tomography findings of benign
792
mediastinal lymph nodes in a tuberculosis-endemic region. Jpn J Radiol2011;29:682–7.
pt Ac ce
793
ed
791
31 Page 31 of 33
793
Figure legends
795
Fig. 1A,B. Case of tubercular lymphadenopathy A Transaxial 18F-FDG PET-CT demonstrated a
796
right supraclavicular lymph node with a maximum standardized uptake value (SUVmax) of
797
5.7. B Coronal slices revealed multiple mediastinal lymph nodes with a SUVmax of 9.9 in the
798
right lower paratracheal region. Hypometabolic areas noted in the nodes are suggestive of
799
casseation/necrosis. The advised site for biopsy was the right supraclavicular lymph node,
800
and histopathology subsequently revealed TB.
801
Fig. 2A,B. Case of tubercular pyelonephritis. A Coronal fused
802
showing two lesions in the middle and the lower pole of the left kidney. BMaximum
803
intensity projection images revealing two foci in the left kidney with no other lesion
804
detected elsewhere in the body.
805
Fig. 3.18F-FDG-avid lesion in the right adnexa (SUVmax 4.4).
F-FDG PET-CT images
an
us
cr
18
ip t
794
806
Fig. 4A,B.99mTc-MDP bone scan (anterior and posterior views) revealing increased tracer
808
uptake in L3–4 vertebrae (A, B), with soft tissue component noted on SPECT-CT and CT
809
images (D, C).
ed
810
M
807
Fig. 5A–F. Case of cervical spondylitis, pretreatment18F-FDG PET-CT (A sagittal view; C
812
coronal view; E MIP), showing contiguous involvement of the C3/C4 vertebrae with a
813
paravertebral component and a SUVmax of 4.4. The corresponding post-treatment PET-CT
814
after 6 months (B, D, F) shows a complete metabolic response.
Ac ce
815
pt
811
18
816
Fig. 6A–F. Case of tubercular spondylitis, pretreatment scanning (A and C sagittal
F-FDG
817
PET-CT and MIP respectively; B CT) that showed disco-vertebral changes with partialcollapse
818
in multiple dorsal lumbar vertebrae. Post-treatment scans (D–F) showed near-complete
819
resolution of all lesions except for mild tracer uptake in the L3 vertebra.
820 821
Fig. 7. An 18F-FDG-avid lesion is noted in the lateral aspect of the medial condyle of the left
822
femur, which is a rare involvement in TB osteomyelitis.
32 Page 32 of 33
823
Fig. 8. Prior to treatment, 18F-FDG-avid lesions are noted in both lungs and the left iliac bone
824
adjoining the sacrum
825
resolution of both the lesions. (bottom row).
(top row). After appropriate treatment, complete metabolic
826 18
Fig. 9. Case of tubercular meningitis. A solitary
F-FDG avid lesion was seen in the right
828
anterior cerebellum (B) which was missed on MRI (A), demonstrating that these modalities
829
may be complementary in identifying brain lesions.
ip t
827
830
Fig. 10.18F-FDG-avid lesion noted along the entire spinal canal prior to treatment (bottom
832
row). The lesion has entirely disappeared following treatment (top row).
us
cr
831
833
Fig. 11A–H. Dual point imaging of the patient at 1 h (A–D) and 3 h (E–H), showing a
835
substantial increase in lesion contrast.
an
834
836
Ac ce
pt
ed
M
837
33 Page 33 of 33
